Skip to main content
. 2018 Mar;59(3):434–441. doi: 10.2967/jnumed.117.202945

TABLE 1.

Treatment Options and Management Changes

Parameter Description
Treatment option* Salvage surgery
Salvage radiation therapy
Metastasis directed ablative radiation therapy (stereotactic body radiation therapy)
Androgen deprivation therapy
Chemotherapy
Bone radionuclide therapy
PSMA radionuclide therapy
Other systemic treatment (vaccine therapy, immunotherapy)
Active surveillance
Management change Conversion to focal treatment/new focal treatment (for either prostate bed, lymph node, or metastasis ablation)
Conversion to systemic treatment
Change in systemic treatment (adding new systemic treatment or removing systemic treatment)
Conversion to active surveillance
*

Multiple treatment options were possible.